"Though human African trypanosomiasis affects thousands of people in sub-Saharan Africa, the absence of a genome-wide map of tsetse biology was a major hindrance for identifying vulnerabilities," said Dr Serap Aksoy, from the University of Yale. "This community of researchers across Africa, Europe, North America and Asia has created a valuable research tool for tackling the devastating spread of sleeping sickness." he said. -- Okey Iheduru, PhD
“Lengo la msingi la Gavi ni kupunguza maradhi na vifo kwa watoto wachanga kupitia chanjo na Pfizer inajivunia kuwa mshirika ikijumuika na washirika wengine katika magonjwa ya pneumococcal kupitia soko la awali la kujitolea ambalo linategemewa kuweza kuepusha magonjwa haya kwa watoto milioni moja kufikia mwaka 2020,” alisema Heather Sings Mkurugenzi wa Chanjo katika Idara ya Matibabu ya Pfizer.